|
Adams JM, Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281:1322-1326 Adnyana IK, Tezuka Y, Banskota AH., Tran KQ., and Kadota S (2001) Three new triterpenes from the seeds of Combretum quadrangulare and their hepatoprotective activity. J. Nat. Prod. 64:360-363 Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW and Yuan J (1996) Human ICE/CED-3 protease nomenlature. Cell 87:171 Anto RJ., Mukhopadhyay A, Denning K and B.Aggarwal B (2002) Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release : its suppression by ectopic expression of Bcl-2 and Bcl-xL. Carcinogenesis 23:143-150 Basu A (1993) The potential of protein kinase c as a target for anticancer treatment. Pharmacol. Therapeut. 59:257-280 Benosmanet A, Richomme P, Roussakis C, Sevenet T, Hadi A. H., Bruneton J (2000) Effects of triterpenes from the stem bark of Dysoxylum cauliflorum on a non-small-cell bronchopulmonary carcinoma cell line (NSCLC-N6). Anticancer Res. 20:1855-1860 Bergmann A, Agapite J and Steller H (1998) Mechanisms and control of programmed cell death in invertebrates. Oncogene 17:3215-3223 Boise LH., Gonzalez-Garcia M, Postema CE., Ding L, Lindsten T, Turka LA., Mao X, Nunez G and Thompson CB. (1993) Bcl-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608 Bortner CD., Oldenburg NBE., Cidlowski JA. (1995) The role of DNA fragmentation in apoptosis. Trends. Cell. Bio. 5:21-26 Boxer LM and Dang CV (2001) Translocations involving c-myc and c-myc function. Oncogene 20:5595-5610 Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR and Ozturk M (1990) Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 87:1973-1977 Brown JM and Wouters BG. (1999) Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res. 59:1391-1399 Bruno S, Tenca C, Saverino D, Ciccone E and Grossi CE (2002) Apoptosis of squamous cells at different stages of carcinogenesis following 4-HPR treatment. Carcinogenesis 23:447-456 Castedo M, Hirsch T, Susin SA, Zamzami N, Marchetti P, Macho A and Kroemer G (1996) Sequential acquisition of mitochondrial and plasma membrane alteration during early lymphocyte apoptosis. Journal. Immunol. 157:512-521
|